Meta-analysis of 5 placebo-controlled RCTs (n=660) in primary biliary cholangitis: PPAR agonists reduced itch scores at 3, 6 and 12 months (MD -1.39 to -1.73) in those with moderate-to-severe itch; no effect on overall quality of life was shown.
Meta-analysisn = 660
Martins et al. Meta-Analysis: PPAR Agonists for Pruritus and Quality of Life in Primary Biliary Cholangitis